Featuring perspectives from Ms Kathryn M Lyle, Dr Ritu Salani, Ms Jaclyn Shaver and Dr Brian M Slomovitz, including the following topics:
- Introduction: Overview of Endometrial Cancer (0:00)
- First-Line Therapy for Advanced or Recurrent Endometrial Cancer (11:01)
- Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced Endometrial Cancer (39:09)
- Novel Investigational Strategies for Newly Diagnosed Advanced Endometrial Cancer (1:00:15)
- Incidence and Management of HER2-Positive Endometrial Cancer (1:17:52)
NCPD information and select publications